Cisplatin-induced genes as potential markers for thyroid cancer

Despite the uncontested role of p53 in cycle arrest/cell death after cisplatin treatment, to date the question whether wild-type p53 confers a resistant or sensitive status on the cell is still a matter of debate. Isogenic and isophenotypic human thyroid papillary carcinoma cell line variants for p53 differently expressed cycle genes after cisplatin treatment. Seven genes (CDC6-related protein, CCNC, GAS1, TFDP2, MAPK10/JNK3, WEE1, RPA1) selected after expression on an Atlas human cell cycle array were analyzed by quantitative real-time PCR. While cisplatin treatment increased their expression in p53 wild-type cells it decreased it in cells with inactivated p53 and had no or less effect on cells with mutated p53. These results show that in a well-defined system, different alterations of p53 can lead to a different regulation of genes and hence to either resistance or sensitivity to cisplatin. Moreover for the first time, MAPK10/JNK3 was identified in human thyroid cells and tissue. Four of the genes (CDC6-related protein, CCNC, GAS1 and TFDP2) were decreased in human papillary carcinoma tissues. Relevance of these genes (especially a decrease in GAS1 in thyroid papillary carcinoma) in various malignant pathologies has already been shown. These genes may be explored as new markers in advanced thyroid cancer such as metastatic and anaplastic forms displaying p53 alterations.Received 26 July 2004; received after revision 14 September 2004; accepted 26 October 2004     

Identification of functional genes during Fas-mediated apoptosis using a randomly fragmented cDNA library

We describe a general strategy for the identification of functional genes that, when downregulated, result in a selectable phenotype. This strategy is based on expression selection of cDNA fragments that counteract their cognate genes. A cDNA library containing random fragments expressed in human HepG2, A375 and CLS-354 cells was used to identify functional genes whose inhibition conferred resistance to Fas-induced apoptosis. Thirty-five clones were isolated, 28 of which were derived from unknown genes, that tagged 19 individual genes and 7 of which referred to known genes that tagged the apoptosis-related protein (APR)-1, -2 and indoleamine-pyrrole 2,3,-dioxygenase (IDO). The ability of APR-1-, -2- and IDO-derived antisense RNAs to induce resistance to Fas in HepG2, A375 and CLS-354 cells suggested that APR-1, -2 and IDO genes are involved in the machinery of Fas-mediated apoptosis. Our gene discovery strategy provides a generally applicable procedure to identify functional genes that interfere with apoptosis, and may therefore be clinically relevant for tumor therapy.Received 28 April 2005; received after revision 20 June 2005; accepted 5 July 2005     

Sequence analysis of mRNA polyadenylation signals of rice genes

Most eukaryotic mRNAs receive a poly (A) tail at their 3′-ends through a process involving the cleavage of pre-mRNA and the concomitant polymerization of adenosine residues to the cleaved RNA end[1,2]. As un- translated regions (UTRs) may contain importa…     

2813条全长人类新基因编码蛋白质的功能预测

用生物信息学序列分析方法对联合基因科技（集团）公司2813条全长人类新基因编码的蛋白质进行了功能预测,由WU－BLASTP核酸 列相似性分析结果表明P值小于le-20的基因合计有466条,占总分析基因的16．57％,P值在le-10以下的基因合计有565条,占总分析基因的20．09％,由蛋白质结构域分析结果表明,含PROSITE Pattern的基因有520条,代表了107种pattern;含PROSITE profile的基因有333条,代表了200种profile;含PFAM结构域的基因有457条,代表了241个family; 含PRINTS的家族指纹1型（class1)的基因有128条,指纹2型（class2) 的有18条,总数为146条,代表了45种家族指纹,由特殊结构分析表明,跨膜蛋白470条,分泌蛋白677条,Coliled-coil蛋白228条,Helix-turn-helix蛋白73条。     

人胎盘G-蛋白Rab3a cDNA的克隆

为了获取全长的小分子G-蛋白Rab3a,以用于研究Rab3a与其他蛋白相互作用关系,本实验以人胎盘总cDNA为模板,PCR扩增到人Rab3a cDNA全编码区。产物回收后克隆于质粒pYESTrp2的BamHI/XhoI位点,测序结果表明,本实验获得的Rab3a cDNA包含了起始和终止密码子。与PCR引物设计的参照Rab3a比较有5个核苷酸变异,与翻译的氨基酸序列完全一致。由此表明本实验获得的Rab3a cDNA可用于进一步研究。     

宫颈癌组织差异表达基因的检测及分析

选取三例经分型明确为HPV16感染的宫颈癌病例,取癌组织(T)、癌旁组织(N)及远瘤正常宫颈组织(F)标本,用Roche NimbleGen芯片系统筛选出差异表达的基因并进行分析.三例标本中,癌组织与远瘤正常宫颈组织相比,差异表达基因共有673个,其中261个上调,412个下调;差异表达基因主要有原癌基因、抑癌基因、细胞信号转导、代谢、免疫应答、细胞受体、蛋白翻译合成有关基因等.